Format

Send to

Choose Destination
EC Pharmacol Toxicol. 2017;SI(1):16-17. Epub 2017 Nov 27.

Is it a Prime Time for AI-powered Virtual Drug Screening?

Author information

1
Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.

Abstract

Drug development pipeline inefficiency has called for more novel solutions and cutting-edge technologies. Artificial intelligence (AI)-based methods including different machine- and deep-learning algorithms have been employed for virtual drug screening. With the continuous refinement of algorithms, improvement of computing hardware, and increased availability of molecular datasets for drug development, it is certainly a prime time for AI-powered virtual drug screening.

KEYWORDS:

Artificial Intelligence; Deep Learning; Drug Discovery; Machine Learning; Virtual Drug Screening

PMID:
30215059
PMCID:
PMC6133253

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center